Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1,133.12%-781.34K | -304.87%-273.67K | 100.26%582 | 139.08%199.92K | -68.38K | 58.40%-63.36K | -115.33%-67.59K | 26.45%-222.77K | -334.79%-511.52K | 0 |
| Net income from continuing operations | 36.65%-535.36K | 41.09%-491.55K | 6.45%-3.93M | 68.14%-1.24M | ---1.01M | -124.34%-845.07K | -1,254.13%-834.34K | -63.74%-4.2M | -125.62%-3.9M | --0 |
| Operating gains losses | ---- | ---- | -70.65%216.75K | ---- | ---- | ---- | ---- | 364.13%738.47K | --867.78K | --0 |
| Depreciation and amortization | -56.34%137.07K | -52.51%135.28K | 20.82%1.42M | -46.14%451.91K | --369.63K | 70.15%313.97K | 87.45%284.84K | 77.46%1.18M | 464.70%839.09K | --0 |
| Asset impairment expenditure | --110.18K | --108.09K | -52.73%388.07K | ---- | ---- | --0 | --0 | 115.57%820.94K | ---- | ---- |
| Remuneration paid in stock | ---38.28K | -1.99%38.28K | --0 | -115.99%-39.06K | --0 | --0 | --39.06K | -71.56%244.22K | -71.56%244.22K | --0 |
| Deferred tax | ---- | ---- | -3,249.75%-783.17K | ---- | ---- | ---- | ---- | 88.44%-23.38K | ---- | ---- |
| Other non cashItems | -43.34%119.31K | -24.29%135.4K | 50.77%930.68K | -21.48%351.48K | --189.79K | 243.27%210.58K | 65.10%178.83K | 2.07%617.29K | -17.00%447.63K | --0 |
| Change In working capital | -260.83%-581.21K | -172.80%-192.22K | 331.59%1.76M | 288.88%745.35K | --390.04K | 79.91%361.39K | 1,609.32%264.02K | 70.27%407.98K | -61.71%191.67K | --0 |
| -Change in receivables | 61.84%-4.1K | 87.21%-1.95K | 33.56%-43.67K | 73.79%-9.44K | ---8.25K | 49.29%-10.73K | -78.30%-15.25K | -2.11%-65.73K | -151.71%-36.02K | --0 |
| -Change in inventory | 118.67%735 | 182.50%2.64K | 299.72%18.84K | 544.45%27.74K | ---1.77K | -162.79%-3.94K | -168.19%-3.19K | -50.65%4.71K | 72.50%-6.24K | --0 |
| -Change in prepaid assets | ---313.6K | 104.16%4.99K | 719.99%69.49K | 416.16%189.49K | --0 | --0 | -636.55%-120K | -156.93%-11.21K | -43.56%-59.93K | --0 |
| -Change in payables and accrued expense | -170.27%-264.25K | -149.17%-197.9K | 216.96%1.73M | 60.67%551.05K | --400.06K | 98.55%376.06K | 2,921.28%402.47K | 60.39%545.69K | -38.84%342.97K | --0 |
| -Change in other working capital | ---- | ---- | 79.41%-13.49K | ---- | ---- | ---- | ---- | 0.00%-65.48K | ---49.11K | --0 |
| Tax refund paid | ---- | ---- | ---- | ---- | ---6.84K | ---- | ---- | ---- | ---- | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1,144.08%-788.29K | -294.59%-266.72K | 100.26%582 | 139.08%199.92K | ---68.38K | 58.40%-63.36K | -115.33%-67.59K | 26.45%-222.77K | -334.79%-511.52K | --0 |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 217.19%12.78K | 104.79%7.82K | 91.15%-231.98K | 93.99%-92.12K | 34.16K | -116.29%-10.9K | 85.89%-163.12K | 9.53%-2.62M | -99.21%-1.53M | 0 |
| Net PPE purchase and sale | 217.19%12.78K | 104.79%7.82K | 88.25%-231.98K | 89.59%-92.12K | --34.16K | ---10.9K | 85.02%-163.12K | 24.16%-1.97M | -19.79%-885.08K | --0 |
| Net business purchase and sale | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -119.07%-648.43K | -1,994.83%-648.43K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 217.19%12.78K | 104.79%7.82K | 91.15%-231.98K | 93.99%-92.12K | --34.16K | -116.29%-10.9K | 85.89%-163.12K | 9.53%-2.62M | -99.21%-1.53M | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 4,000.72%2.65M | 31.32%241.31K | -96.35%88.91K | -100.95%-18.04K | -8.85K | -115.39%-67.96K | 106.61%183.76K | 568.18%2.43M | 974.06%1.9M | 0 |
| Net issuance payments of debt | 16.40%-7.2K | 11.97%241.31K | -90.91%189.42K | -100.41%-8.63K | ---8.85K | 69.20%-8.61K | 2,048.90%215.51K | 7,353.43%2.08M | 10,857.22%2.12M | --0 |
| Net common stock issuance | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 2,191.67%550K | -181.25%-19.5K | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -95.94%15K | ---- | ---- |
| Interest paid (cash flow from financing activities) | --0 | --0 | 8.94%-98.75K | 92.95%-7.65K | --0 | ---59.35K | ---31.75K | ---108.45K | ---108.45K | --0 |
| Net other financing activities | ---- | ---- | 98.35%-1.76K | ---- | ---- | ---- | ---- | ---106.58K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 4,000.72%2.65M | 31.32%241.31K | -96.35%88.91K | -100.95%-18.04K | ---8.85K | -115.39%-67.96K | 106.61%183.76K | 568.18%2.43M | 974.06%1.9M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -52.72%102.96K | -55.06%127.63K | -59.36%283.98K | -86.99%14.16K | -36.88%68.65K | 98.67%217.76K | -59.36%283.98K | -80.08%698.83K | -92.64%108.76K | -95.40%108.76K |
| Current changes in cash | 1,411.82%1.87M | 62.53%-17.59K | 65.33%-142.49K | 163.58%89.76K | ---43.07K | -139.93%-142.23K | 92.50%-46.95K | 85.52%-410.92K | 81.66%-141.19K | --0 |
| Effect of exchange rate changes | 273.79%11.96K | 63.25%-7.08K | -252.56%-13.87K | -92.51%23.71K | ---11.43K | 98.07%-6.88K | -152.53%-19.27K | -114.26%-3.93K | 3,407.29%316.41K | --0 |
| End cash Position | 2,785.22%1.98M | -52.72%102.96K | -55.06%127.63K | -55.06%127.63K | -86.99%14.16K | -36.88%68.65K | 98.67%217.76K | -59.36%283.98K | -59.36%283.98K | -92.64%108.76K |
| Free cash from | -961.43%-788.29K | -15.61%-266.72K | 89.47%-231.39K | 107.72%107.8K | ---34.22K | 51.24%-74.27K | 64.39%-230.71K | 24.40%-2.2M | -168.06%-1.4M | --0 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.